Seeking Alpha

Heavily-shorted Questcor (QCOR +6.1%) surges after receiving more positive sell-side commentary...

Heavily-shorted Questcor (QCOR +6.1%) surges after receiving more positive sell-side commentary (previous), this time from Jefferies, which is upgrading shares to Buy. Analyst Biren Amin believes investors are pricing Questcor as if almost no insurers will provide coverage for its Acthar gel for treating nephrotic syndrome or MS, something he considers unrealistic.
Comments (1)
  • Momintn
    , contributor
    Comments (3822) | Send Message
     
    85% of prescriptions were reimbursed.
    10 Oct 2012, 12:40 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|